阿加曲班_ARGATROBAN_阿加曲班水合物说明书

  [caption id="attachment_39994" align="alignleft" width="300"] ARGATROBAN VL 50MG 50ML(ARGATROBAN IN NACL ISO-OSMOTIC 阿加曲班水合物)[/caption] 药店国别: 产地国家:美国 处 方 药:所属类别:50毫克/50毫升/瓶 10瓶/盒 包装规格:50毫克/50毫升/瓶 10瓶/盒 计价单位:生产厂家中文参考译名:山德士制药 生产厂家英文名:Sandoz 原产地英文商品名:ARGATROBAN VL 50MG 50ML SAN10= 原产地英文药品名:ARGATROBAN IN NACL ISO-OSMOTIC 中文参考商品译名:ARGATROBAN注射剂 50毫克/50毫升/瓶 10瓶/盒 中文参考药品译名:阿加曲班水合物 简介: ARGATROBAN(阿加曲班 Argatroban hydrate)注射液,用于静脉内使用 美国初始批准:2000 目前的主要变化 剂量和给药方法,剂量患者经皮冠状动脉介入 5/2016 作用机理: 阿加曲班是直接的凝血酶抑制剂可逆地结合凝血酶的活性位点。阿加曲班不需要用于抗血栓活性的辅因子抗凝血酶III。阿加曲班通过发挥抑制凝血酶催化或诱导的反应,包括纤维蛋白形成的抗凝血作用;凝血因子活化第五,第八和第十三;蛋白C的活化;和血小板聚集。 阿加曲班抑制凝血酶与0:04.mu.M的抑制常数(Ki)。在治疗浓度,阿加曲班对相关丝氨酸蛋白酶(胰蛋白酶,因子Xa,纤溶酶,和激肽释放酶)很少或没有影响。 阿加曲班能够抑制免费和血块相关凝血酶的作用的。 适应症和用法: 阿加曲班是直接凝血酶抑制剂表示: 用于预防或治疗血栓形成在成人闪现与肝素诱导的血小板减少症(HIT)的。 作为成年人哈斯塔抗凝剂与或有HIT经皮冠状动脉介入治疗(PCI)的风险。 用法用量: 阿加曲班注射250毫克/2.5毫升(100毫克/毫升),必须通过用0.9%氯化钠注射液,5%的葡萄糖注射液,或乳酸林格氏注射液的1毫克/毫升的最终浓度混合来稀释100倍。 阿加曲班注射50毫克/ 50毫升(1毫克/毫升)是准备用于静脉内输注。不需要稀释。 肝素诱导的血小板 对于无肝脏损害肝素诱导的血小板减少症的剂量为2微克/公斤/分钟给药作为连续输注。 经皮冠状动脉介入 用或在肝素诱导的血小板减少经皮冠状动脉介入,在25微克/kg/分钟,通过在3至5分钟的大孔静脉线经管350微克/kg大丸剂启动风险剂量为闪现。 表格和剂量规格: 注射:250毫克/2.5毫升(100毫克/毫升)的单剂量小瓶中。 注射:50毫克/50毫升(1毫克/毫升)准备在单剂量小瓶静脉输注。 禁忌症: 严重出血 过敏史本产品 警告和注意事项: 出血的生活是OCC。不明原因下降,红细胞压积或血压可能表明出血, 肝损害:调整起始剂量及患者就打谁有中度或切断肝功能损害仔细滴定。应避免与有临床意义的肝功能损害患者在PCI使用。 ADV如果反应 哈斯塔HIT:最常见(>5%)进阶如果反应是呼吸困难,低血压,发烧,腹泻,败血症和心脏骤停。 PCI闪现:最常见(>5%)进阶如果反应是胸痛,低血压,背部疼痛,恶心,呕吐和头痛。 药物相互作用 肝素:允许有足够的时间对肝素的对APTT的影响开始治疗阿加曲班注射前减少。 华法林:增加与prolongatio同时使用的PT和INR结果。 尚未建立安全和阿加曲班同时使用情况和效果:溶栓药物或糖蛋白IIb/ IIIa受体拮抗剂。 人群中使用特定IN 哺乳母亲:终止哺乳或药物,考虑到药物的önem给母亲。 儿童用药:安全性和有效性尚未确定。   GENERIC NAME: ARGATROBAN - INJECTION (ar-GAH-troh-ban) USES: Argatroban is a type of "blood thinner" used instead of heparin to prevent blood clots during certain procedures to open up the blood vessels in the heart (e.g., balloon angioplasty, coronary stentplacement, percutaneous coronary intervention-PCI). It is usually used with aspirin. It is also used to treat and prevent harmful blood clots and increase platelets in patients who have had a reaction to heparin (e.g., heparin-induced thrombocytopenia-HIT).Argatroban works by blocking a certain natural substance (thrombin) that the body uses to form blood clots. Blood clots can cause a heart attack, stroke, gangrene, or cause the opened blood vessel in the heart to close back up. HOW TO USE: Follow all instructions for proper mixing and dilution with the correct IV fluids. If you have questions about using this medication properly, consult your pharmacist.Before using this product, check it visually for particles or discoloration. If either is present, do not use the liquid.This medication is usually given by injection into a vein over 3 to 5 minutes (bolus dose) by a health care professional before your procedure. It is then given slowly into a vein (by infusion) during your procedure. More bolus doses may be given during the procedure. The infusion may be continued after your procedure as directed by your doctor.If you are being treated for a platelet problem (e.g., HIT), the drug is usually given slowly into a vein without a bolus dose or as directed by your doctor. The dosage is based on your weight, medical condition, and response to treatment. Your doctor will order blood-clotting tests to find the best dose for you.After your procedure, you will need to lie very still with your head up slightly. The tube for your procedure is usually placed near the groin. Keep the leg (or other limb nearest the tube) straight to prevent bleeding from the tube area. Pressure will be applied to the area (e.g., with a sandbag, special pressure dressing/device). You will not be allowed out of bed for several hours after the procedure.
用药温馨提示:当您服用此药物时,需定期接受医疗专业人士的检查,以便随时针对其药效、副作用等情况进行监测。本网站所包含的信息旨在为患者提供帮助,不能代替医学建议和治疗。
药品价格查询,专业药品查询网站,药品说明书查询,药品比价 » 阿加曲班_ARGATROBAN_阿加曲班水合物说明书

提供最优质的资源集合

药品说明书 药品比价